InvestorsHub Logo
Followers 5
Posts 240
Boards Moderated 0
Alias Born 04/12/2018

Re: JNdouble1 post# 164674

Thursday, 12/13/2018 7:39:20 PM

Thursday, December 13, 2018 7:39:20 PM

Post# of 333764
Wow! It would appear that while AW fiddles Rome burns! How in the hell does a 2011 start up surpass BIEL with their own version of Actipatch? Endonovo has something called Sofpulse. It looks remarkably like our Actdipatch and apparently works the same. Is there a possible patent infringement issue here?

When will BIEL start to advertise? The silence from the company is deafening and in my opinion is hurting our prospects as other companies are now entering the personal medical device bioelectronic space. I've seen this happen with another company, they had the best technology, were years ahead of the competition, but they sat on their hands and now the stock is virtually worthless. What a shame it would be to see something similar happen here.

TheRealHeisenberg